Sign Up to like & get
recommendations!
0
Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.0023
Abstract: Telomerase reactivation via mutations in the telomerase reverse transcriptase promoter (TERTp) is a recurrent feature of glioblastoma, enabling replicative immortality in ~80% of patient cases and presents a critical oncogenic event attractive for therapeutic targeting.…
read more here.
Keywords:
tertp;
mutant allele;
glioblastoma;
crisproff ... See more keywords